Public Employees Retirement System of Ohio raised its stake in West Pharmaceutical Services Inc. (NYSE:WST) by 20.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 46,898 shares of the medical instruments supplier’s stock after acquiring an additional 7,878 shares during the quarter. Public Employees Retirement System of Ohio owned about 0.06% of West Pharmaceutical Services worth $6,651,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in the business. Krane Funds Advisors LLC acquired a new stake in West Pharmaceutical Services during the 2nd quarter worth approximately $26,000. Steward Partners Investment Advisory LLC acquired a new position in West Pharmaceutical Services in the 2nd quarter valued at $40,000. Advisory Services Network LLC grew its holdings in West Pharmaceutical Services by 84.5% in the 2nd quarter. Advisory Services Network LLC now owns 393 shares of the medical instruments supplier’s stock valued at $49,000 after buying an additional 180 shares in the last quarter. FMR LLC increased its position in West Pharmaceutical Services by 41.3% during the 1st quarter. FMR LLC now owns 794 shares of the medical instruments supplier’s stock worth $88,000 after buying an additional 232 shares during the period. Finally, Quest Capital Management Inc. ADV bought a new position in West Pharmaceutical Services during the 3rd quarter worth $113,000. 90.21% of the stock is currently owned by hedge funds and other institutional investors.
Shares of WST opened at $149.43 on Tuesday. West Pharmaceutical Services Inc. has a 12 month low of $91.75 and a 12 month high of $152.10. The firm’s 50 day moving average is $145.39 and its 200-day moving average is $135.43. The stock has a market capitalization of $10.88 billion, a PE ratio of 53.18, a P/E/G ratio of 3.34 and a beta of 1.24. The company has a current ratio of 3.00, a quick ratio of 2.31 and a debt-to-equity ratio of 0.17.
West Pharmaceutical Services (NYSE:WST) last released its quarterly earnings results on Thursday, October 24th. The medical instruments supplier reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.08. The company had revenue of $456.10 million during the quarter, compared to the consensus estimate of $450.03 million. West Pharmaceutical Services had a net margin of 12.82% and a return on equity of 16.66%. The firm’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the business earned $0.76 earnings per share. Equities research analysts predict that West Pharmaceutical Services Inc. will post 3.14 earnings per share for the current fiscal year.
WST has been the subject of a number of recent research reports. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $160.00 target price for the company in a research report on Sunday, November 3rd. ValuEngine lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. West Pharmaceutical Services presently has an average rating of “Hold” and an average price target of $131.39.
West Pharmaceutical Services Profile
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
See Also: Backdoor Roth IRA Conversion and Strategy
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.